Cilostazol Protects Diabetic Rats from Vascular Inflammation via Nuclear Factor-κB-Dependent Down-Regulation of Vascular Cell Adhesion Molecule-1 Expression

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.106.101444PMID 16595735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes Mellitus Receptor Antagonist S 18886 Prevents Enhanced Atherogenesis 2 The Thromboxane

  2005cited by this paper
• Functional Abnormalities in Isolated Arteries from Goto-Kakizaki and Streptozotocin-treated Diabetic Rat Models

  2005cited by this paper
• Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis

  2005cited by this paper
• Glutathione depletion inhibits lipopolysaccharide-induced intercellular adhesion molecule 1 synthesis.

  2005cited by this paper
• Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus.

  2005influential reference
• Cilostazol Reduces Atherosclerosis by Inhibition of Superoxide and Tumor Necrosis Factor-α Formation in Low-Density Lipoprotein Receptor-Null Mice Fed High Cholesterol

  2005cited by this paper
• Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis

  2005cited by this paper
• Diabetes and cardiovascular risk markers

  2005cited by this paper
• Cilostazol Prevents Remnant Lipoprotein Particle-Induced Monocyte Adhesion to Endothelial Cells by Suppression of Adhesion Molecules and Monocyte Chemoattractant Protein-1 Expression via Lectin-Like Receptor for Oxidized Low-Density Lipoprotein Receptor Activation

  2005influential reference
• Inhibition of Mammalian Target of Rapamycin Potentiates Thrombin-Induced Intercellular Adhesion Molecule-1 Expression by Accelerating and Stabilizing NF-κB Activation in Endothelial Cells 1

  2005cited by this paper
• Selective Inhibition of Protein Kinase Cβ2 Prevents Acute Effects of High Glucose on Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

  2004cited by this paper
• Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation.

  2004cited by this paper
• Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.

  2004cited by this paper
• Cilostazol inhibits high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production.

  2004influential reference
• Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients.

  2004cited by this paper
• Cilostazol Prevents Remnant Lipoprotein Particle-induced Monocyte Adhesion to Endothelial Cells by Suppression of Adhesion Molecules and MCP-1 Expression via LOX-1 Receptor Activation

  2004influential reference
• Role of nuclear factor-kappa B in the regulation of intercellular adhesion molecule 1 after infection of human bronchial epithelial cells by Bordetella pertussis.

  2003cited by this paper
• Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells.

  2003cited by this paper
• Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells.

  2003influential reference
• DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha.

  2002cited by this paper
• Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus.

  2002cited by this paper
• A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes

  2002cited by this paper
• [Effect of cilostazol on adhesion molecules of STZ-induced diabetic rats].

  2002cited by this paper
• DNA Binding-Independent Induction of IκBα Gene Transcription by PPARα

  2002influential reference
• Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?

  2001cited by this paper
• Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.

  2001cited by this paper
• Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus.

  2001cited by this paper
• Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence.

  2001cited by this paper
• Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC.

  2001cited by this paper
• Nuclear Factor-κB Suppressive and Inhibitor-κB Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?1

  2001cited by this paper
• Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients.

  1999cited by this paper
• The combined role of P- and E-selectins in atherosclerosis.

  1998cited by this paper
• Cilostazol, a cAMP Phosphodiesterase Inhibitor, Attenuates the Production of Monocyte Chemoattractant protein-1 in Response to Tumor Necrosis Factor-α in Vascular Endothelial Cells

  1997cited by this paper
• The critical role of intercellular adhesion molecule-1 in Masugi nephritis in rats.

  1996influential reference
• The Effects of Streptozotocin-induced Diabetes and Insulin Supplementation on Expression of the Glycogen Phosphorylase Gene in Rat Liver (*)

  1995influential reference
• Activation of NF‐κB by cAMP in human myeloid cells

  1993cited by this paper
• Activation of NF-kappa B by cAMP in human myeloid cells.

  1993cited by this paper

• Dual Inhibition of Phosphodiesterase 3 and 4 Enzymes by Ensifentrine Protects against MRSA-Induced Lung Endothelial and Epithelial Dysfunction

  2024cites this paper
• Heat therapy: Mechanistic underpinnings and applications to cardiovascular health.

  2021cites this paper
• Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target

  2020cites this paper
• Effects of Nigella sativa on endothelial dysfunction in diabetes mellitus; A review.

  2020cites this paper
• Possible mechanisms mediating the protective effect of cilostazol in L-arginine induced acute pancreatitis in rats: role of cGMP, cAMP, and HO-1

  2020influential citation
• Vardenafil and cilostazol can improve vascular reactivity in rats with diabetes mellitus and rheumatoid arthritis co-morbidity.

  2019cites this paper
• UTILIZATION OF DISSOLUTION RATE IMPROVEMENT EFFECT OF DIFFERENT HYDROPHILIC POLYMERS ON ANTIPLATELET DRUG (CILOSTAZOL) VIA SOLID DISPERSION TECHNIQUE

  2019cites this paper
• Cilostazol Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E–Deficient Mice

  2018cites this paper
• Anti‐inflammatory properties of cilostazol: Its interruption of DNA binding activity of NF‐&kgr;B from the Toll‐like receptor signaling pathways

  2018cites this paper
• Beneficial effects of cilostazol on liver injury induced by common bile duct ligation in rats: Role of SIRT1 signaling pathway

  2018cites this paper
• Low-level laser irradiation modifies the effect of hyperglycemia on adhesion molecule levels

  2018cites this paper
• Cilostazol Attenuates AngII-induced Abdominal Aortic Aneurysms But Not Atherosclerosis in ApoE Deficient Mice

  2018cites this paper
• Chapter 15 Antioxidants in Decelerating Diabetic Nephropathy

  2017cites this paper
• Effect of cilostazol in treating diabetes-associated microvascular complications

  2017cites this paper
• Macro‐ and microvascular endothelial dysfunction in diabetes

  2017cites this paper
• Alteration in Inflammation-related miR-146a Expression in NF-KB Signaling Pathway in Diabetic Rat Hippocampus

  2016cites this paper
• Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice.

  2015cites this paper
• Pulmonary, gastrointestinal and urogenital pharmacologyCilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats

  2015cites this paper
• Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial

  2014cites this paper
• Cilostazol Renoprotective Effect: Modulation of PPAR-γ, NGAL, KIM-1 and IL-18 Underlies Its Novel Effect in a Model of Ischemia-Reperfusion

  2014cites this paper
• The Endothelial Response to Injury: Defining the Role of Epidermal Growth Factor-like Domain 7 and Endothelial Protective Strategies

  2014cites this paper
• MicroRNA-146a expression and its intervention in NF-кB signaling pathway in diabetic rat aorta.

  2014influential citation
• A novel hemostatic sealant composed of gelatin, transglutaminase and thrombin effectively controls liver trauma-induced bleeding in dogs

  2013cites this paper
• Antioxidants in Decelerating Diabetic Nephropathy

  2013cites this paper
• Oxidative Stress in Diabetic Nephropathy

  2013cites this paper
• Indomethacin-induced small intestinal injury is ameliorated by cilostazol, a specific PDE-3 inhibitor

  2012cites this paper
• Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model

  2012cites this paper
• Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.

  2012cites this paper
• Curcumin increases vasodilatory effect of cilostazol in diabetic rat aorta.

  2012cites this paper
• Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol.

  2011cites this paper
• Cilostazol minimizes venous ischemic injury in diabetic and normal rats

  2011cites this paper
• Cilostazol Ameliorates Nephropathy in Type 1 Diabetic Rats Involving Improvement in Oxidative Stress and Regulation of TGF-β and NF-κB

  2010cites this paper
• Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis?

  2010cites this paper
• Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB.

  2010cites this paper
• Antioxidant and hepatoprotective effects of extract of ginkgo biloba in rats of non-alcoholic steatohepatitis.

  2010cites this paper
• Inflammation Determines the Pro-Adhesive Properties of High Extracellular D-Glucose in Human Endothelial Cells In Vitro and Rat Microvessels In Vivo

  2010cites this paper
• Cilostazol attenuates cerebral vasospasm after experimental subarachnoid hemorrhage

  2010cites this paper
• The Renal Protective Effects of Cilostazol on Suppressing Pathogenic Thrombospondin-1 and Transforming Growth Factor-β Expression in Streptozotocin-Induced Diabetic Rats

  2009cites this paper
• Tissue-specific expression of PPAR mRNAs in diabetic rats and divergent effects of cilostazol.

  2008cites this paper
• Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.

  2008cites this paper
• Effects of Cilostazol on Thrombospondin-1 (TSP-1) Expression Changes in the Myocardium of Diabetic Rats

  2008cites this paper
• Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis.

  2008cites this paper
• Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate

  2007cites this paper
• Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP.

  2007cites this paper